| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $106.7M | — | -5.8% |
| Cost of Revenue | $71.1M | — | -4.3% |
| Gross Profit | $35.6M | — | -8.7% |
| R&D Expense | $2.1M | — | -10.7% |
| SG&A Expense | $41.2M | — | -3.7% |
| Operating Income | -$5.6M | — | -48.4% |
| Interest Expense | $60K | — | -61.3% |
| Pre-tax Income | -$5.1M | — | -44.7% |
| Income Tax | -$849K | — | +27.0% |
| Net Income | -$4.3M | — | -79.7% |
| EPS (Basic) | -$0.37 | — | -76.2% |
| EPS (Diluted) | -$0.37 | — | -76.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $62.8M | +20.4% | +6.2% |
| Accounts Receivable | $93.2M | -32.6% | -2.5% |
| Inventory | $52.9M | -11.6% | -0.6% |
| Current Assets | $228.8M | -15.0% | +0.4% |
| Total Assets | $400.4M | -9.4% | -1.3% |
| Current Liabilities | $117.0M | -21.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $21.8M | — | +1382.1% |
| Capital Expenditures | $5.6M | — | +170.0% |
| Investing Cash Flow | -$5.8M | — | -89.6% |
| Financing Cash Flow | -$4.3M | — | +35.4% |
| Free Cash Flow | $16.2M | — | +529.9% |
| -1.5% |
| Total Liabilities | $158.5M | -17.9% | -7.2% |
| Stockholders' Equity | $242.0M | -2.9% | +3.2% |